DE3586420D1 - Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. - Google Patents

Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.

Info

Publication number
DE3586420D1
DE3586420D1 DE8585115605T DE3586420T DE3586420D1 DE 3586420 D1 DE3586420 D1 DE 3586420D1 DE 8585115605 T DE8585115605 T DE 8585115605T DE 3586420 T DE3586420 T DE 3586420T DE 3586420 D1 DE3586420 D1 DE 3586420D1
Authority
DE
Germany
Prior art keywords
dihydropyridines
arteriosclerosis
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585115605T
Other languages
English (en)
Other versions
DE3586420T2 (de
Inventor
Isamu Yamaguchi
Jiro Hirosumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3586420D1 publication Critical patent/DE3586420D1/de
Publication of DE3586420T2 publication Critical patent/DE3586420T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585115605T 1984-12-10 1985-12-07 Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. Expired - Fee Related DE3586420T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848431119A GB8431119D0 (en) 1984-12-10 1984-12-10 Anti-arteriosclerotic composition

Publications (2)

Publication Number Publication Date
DE3586420D1 true DE3586420D1 (de) 1992-09-03
DE3586420T2 DE3586420T2 (de) 1993-01-07

Family

ID=10570949

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585115605T Expired - Fee Related DE3586420T2 (de) 1984-12-10 1985-12-07 Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.

Country Status (5)

Country Link
US (1) US4859688A (de)
EP (1) EP0185283B1 (de)
JP (1) JPS61155327A (de)
DE (1) DE3586420T2 (de)
GB (1) GB8431119D0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782070A (en) * 1986-07-01 1988-11-01 Fujisawa Pharmaceutical Co., Ltd. Cerebral dysfunction therapeutic agent, which comprises a dihydropyridine compound
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
ES2070307T3 (es) * 1990-07-04 1995-06-01 Marcin Krotkiewski Una preparacion para el tratamiento de la hipertension.
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
DK1628663T3 (da) * 2003-05-15 2010-03-08 Roskamp Res Llc Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose
US20100093810A1 (en) * 2007-10-05 2010-04-15 Alzheimer's Institute Of America, Inc. Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis
DK2214666T3 (da) * 2007-10-05 2014-01-27 Alzheimer S Inst Of America Inc Fremgangsmåde til reducering af amyloid-afsætning, amyloid-neurotoksicitet og mikrogliose med (-)-nilvadipin-enantiomer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4150119A (en) * 1976-10-22 1979-04-17 Jesus Emilio Lince Isaza Method for treatment of vascular disease
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0125803A3 (de) * 1983-04-27 1987-01-21 FISONS plc Pharmazeutisch aktive Dihydropyridine

Also Published As

Publication number Publication date
GB8431119D0 (en) 1985-01-16
EP0185283A3 (en) 1989-07-19
JPS61155327A (ja) 1986-07-15
DE3586420T2 (de) 1993-01-07
JPH0529209B2 (de) 1993-04-28
US4859688A (en) 1989-08-22
EP0185283B1 (de) 1992-07-29
EP0185283A2 (de) 1986-06-25

Similar Documents

Publication Publication Date Title
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE68920775D1 (de) Behandlung von faserigen Materialien.
DE69224080D1 (de) Verwendung von nsaid zur behandlung von demenz
DE68929554D1 (de) Piperazinyl-substituierte Phenylpyrimidinderivative zur Behandlung oder Vorbeugung von ZNS Erkrankungen
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DE3780972D1 (de) Verwendung von spezifischen n-methyl-d-aspartat-rezeptor-antagonisten zur praevention und behandlung von neurodegeneration.
DE69212620D1 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
DE3888056D1 (de) Oxadiazolyl-azabicycloheptane zur Behandlung von seniler Demenz.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE68909068D1 (de) Behandlung von anorganischen Baumaterialien.
DE69004301D1 (de) Mischung zur Behandlung der von exokrinen Insuffizienz der Bauchspeicheldrüse und die Verwendung der genannten Mischung.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE3785555D1 (de) Verwendung von guaifenesin zur behandlung urologischer beschwerden.
DE68908404D1 (de) Lang haltende zusammensetzung von propafenon und chinidin zur behandlung des zustandes des herzens.
DE68917616D1 (de) Demulgator-Zusammensetzungen und Herstellungsmethode und Verwendung.
DE68913779D1 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.
DE69715878D1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
DE68929177D1 (de) Verwendung von Dihydropyridinen zur Vorbeugung und Behandlung cerebraler Durchblutungsstörungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee